Abstract
Glioma is the most common malignant tumor in the nervous system in adults. Searching highly specific therapeutic targets of glioma cells have become a new direction for research in recent years with the evolvement of molecular biological technology. Indeed, heat shock protein family (HSPs) plays an important role in the immunity, proliferation, invasion and metastasis of glioma cells. In recent years, HSP27, HSP70, HSP90 are contained in research hotspots of HSPs and they are strongly associated with the diagnosis, treatment and prognosis of glioma proved by numerous studies. All these findings indicate that HSPs is expected to become a new target for glioma treatment in the future. However, with its potential as a therapeutic target for glioma, enhancing targeting of HSPs remains to be a chief problem to be solved. Key words: Glioma; Heat shock protein; Tumor vaccine; Target therapy
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
